CSBR
Champions Oncology, Inc.
Price Chart
Latest Quote
$6.32
-0.50 (-7.33%)
Current Price
| Previous Close | $6.82 |
| Open | $6.73 |
| Day High | $6.73 |
| Day Low | $6.32 |
| Volume | 4,752 |
Stock Information
| Shares Outstanding | 13.89M |
| Total Debt | $5.00M |
| Cash Equivalents | $7.13M |
| Revenue | $57.95M |
| Net Income | $-2.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $87.76M |
| EPS (TTM) | $-0.18 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $85.73M |
| Sales | $57.95M |
| Income | $-2.34M |
| Book/sh | $0.31 |
| Cash/sh | $0.51 |
| Employees | 213 |
Financial Ratios
| Quick Ratio | 0.93 |
| Current Ratio | 0.98 |
| Debt/Eq | 114.19 |
Returns & Margins
| ROA | -4.70% |
| ROE | -47.59% |
| Gross Margin | 45.88% |
| Operating Margin | -1.13% |
| Profit Margin | -4.04% |
Ownership
| Insider Ownership | 26.67% |
| Institutional Ownership | 47.74% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 63.20 |
| P/S | 1.51 |
| P/B | 20.52 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $6.03 |
| SMA50 | $6.00 |
| SMA200 | $6.39 |
| RSI | 59.23 |
| ATR | 0.3293 |
| Shares Float | 5.19M |
| Short Float | 1.19% |
| Short Ratio | 7.46 |
| Volatility | 0.40 |
| Rel Volume | 0.61 |
Performance History
| Week | -1.56% |
| Month | +5.69% |
| Quarter | +1.94% |
| 6 Months | -6.09% |
| YTD | -5.11% |
| Year | -21.49% |
| 3 Years | +14.49% |
| 5 Years | -34.03% |
| 10 Years | +180.89% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $6.32 | 5,200 |
| 2026-06-17 | $6.82 | 3,100 |
| 2026-06-16 | $6.88 | 16,700 |
| 2026-06-15 | $6.34 | 8,800 |
| 2026-06-12 | $6.50 | 4,400 |
| 2026-06-11 | $6.42 | 11,200 |
| 2026-06-10 | $5.72 | 1,800 |
| 2026-06-09 | $5.79 | 5,800 |
| 2026-06-08 | $5.64 | 8,200 |
| 2026-06-05 | $5.65 | 900 |
| 2026-06-04 | $5.76 | 1,600 |
| 2026-06-03 | $5.69 | 13,100 |
| 2026-06-02 | $5.73 | 3,500 |
| 2026-06-01 | $5.84 | 9,800 |
| 2026-05-29 | $5.84 | 12,300 |
| 2026-05-28 | $5.85 | 20,900 |
| 2026-05-27 | $5.87 | 4,600 |
| 2026-05-26 | $5.99 | 6,300 |
| 2026-05-22 | $6.01 | 10,500 |
| 2026-05-21 | $5.95 | 22,900 |
| 2026-05-20 | $6.05 | 8,200 |
| 2026-05-19 | $5.98 | 16,200 |
About Champions Oncology, Inc.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
đ° Latest News
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...
GuruFocus.com âĸ 2026-03-19T01:00:24ZChampions Oncology (CSBR) Earnings Transcript
Motley Fool âĸ 2026-03-13T13:26:11Z
Champions Oncology, Inc. Q3 2026 Earnings Call Summary
Moby âĸ 2026-03-13T12:30:00Z
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge
Motley Fool âĸ 2026-02-20T16:39:14Z
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year
Motley Fool âĸ 2026-02-20T16:29:26Z
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know
Motley Fool âĸ 2026-02-20T16:21:17Z
Is Champions Oncology, Inc.'s (NASDAQ:CSBR) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. âĸ 2026-01-17T12:17:26Z
Champions Oncology (CSBR) Earnings Call Transcript
Motley Fool âĸ 2026-01-07T15:16:03Z
Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2025-12-16T05:00:31ZShareholders in Champions Oncology (NASDAQ:CSBR) are in the red if they invested five years ago
Simply Wall St. âĸ 2025-12-07T12:04:10Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $28,389,000 | $29,401,000 | $29,532,000 | $23,632,000 |
| Cost Of Revenue | $28,389,000 | $29,401,000 | $29,532,000 | $23,632,000 |
| Total Revenue | $56,944,000 | $50,155,000 | $53,870,000 | $49,109,000 |
| Operating Revenue | $56,944,000 | $50,155,000 | $53,870,000 | $46,882,000 |
| Expenses | ||||
| Total Expenses | $52,098,000 | $57,076,000 | $58,319,000 | $48,502,000 |
| Other Income Expense | $-220,000 | $-387,000 | $-818,000 | $-24,000 |
| Other Non Operating Income Expenses | $73,000 | $48,000 | $-11,000 | $-24,000 |
| Operating Expense | $23,709,000 | $27,675,000 | $28,787,000 | $24,870,000 |
| Selling And Marketing Expense | $7,545,000 | $7,064,000 | $7,002,000 | $6,379,000 |
| General And Administrative Expense | $9,339,000 | $11,067,000 | $10,240,000 | $9,117,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Normalized Income | $4,932,470 | $-6,843,175 | $-4,697,470 | $548,000 |
| Net Income From Continuing And Discontinued Operation | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Total Operating Income As Reported | $4,553,000 | $-7,356,000 | $-5,256,000 | $607,000 |
| Net Income Common Stockholders | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Net Income | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Net Income Including Noncontrolling Interests | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Net Income Continuous Operations | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Pretax Income | $4,626,000 | $-7,308,000 | $-5,267,000 | $583,000 |
| Special Income Charges | $-293,000 | $-435,000 | $-807,000 | $0 |
| Operating Income | $4,846,000 | $-6,921,000 | $-4,449,000 | $607,000 |
| Gross Profit | $28,555,000 | $20,754,000 | $24,338,000 | $25,477,000 |
| Per Share | ||||
| Diluted EPS | $0.33 | $-0.54 | $-0.39 | $0.04 |
| Basic EPS | $0.34 | $-0.54 | $-0.39 | $0.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $-61,530 | $-2,175 | $-169,470 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $6,779,000 | $-4,619,000 | $-1,396,000 | $2,234,000 |
| Total Unusual Items | $-293,000 | $-435,000 | $-807,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-293,000 | $-435,000 | $-807,000 | $0 |
| Reconciled Depreciation | $1,640,000 | $1,867,000 | $2,246,000 | $1,627,000 |
| EBITDA (Bullshit earnings) | $6,486,000 | $-5,054,000 | $-2,203,000 | $2,234,000 |
| EBIT | $4,846,000 | $-6,921,000 | $-4,449,000 | $607,000 |
| Diluted Average Shares | $14,266,781 | $13,547,604 | $13,541,559 | $14,159,799 |
| Basic Average Shares | $13,659,786 | $13,547,604 | $13,541,559 | $13,197,170 |
| Diluted NI Availto Com Stockholders | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Tax Provision | $-75,000 | $-32,000 | $68,000 | $35,000 |
| Gain On Sale Of Ppe | $-293,000 | $-435,000 | $0 | - |
| Research And Development | $6,825,000 | $9,544,000 | $11,545,000 | $9,374,000 |
| Selling General And Administration | $16,884,000 | $18,131,000 | $17,242,000 | $15,496,000 |
| Other Gand A | $9,339,000 | $11,067,000 | $10,240,000 | $9,117,000 |
| Write Off | - | $0 | $807,000 | $0 |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-06-13
Balance Sheet (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,437,000 | $-2,238,000 | $4,301,000 | $8,761,000 |
| Total Assets | $32,344,000 | $26,132,000 | $34,311,000 | $35,378,000 |
| Total Non Current Assets | $9,975,000 | $12,493,000 | $14,854,000 | $15,714,000 |
| Other Non Current Assets | $185,000 | $185,000 | $15,000 | $15,000 |
| Goodwill And Other Intangible Assets | $335,000 | $335,000 | $335,000 | $335,000 |
| Current Assets | $22,369,000 | $13,639,000 | $19,457,000 | $19,664,000 |
| Other Current Assets | $1,350,000 | $1,495,000 | $1,328,000 | $1,144,000 |
| Receivables | $11,234,000 | $9,526,000 | $8,011,000 | $9,513,000 |
| Receivables Adjustments Allowances | $-1,029,000 | $-1,301,000 | $-825,000 | $-630,000 |
| Other Receivables | $5,398,000 | $5,941,000 | $4,993,000 | $4,106,000 |
| Accounts Receivable | $6,865,000 | $4,886,000 | $3,843,000 | $6,037,000 |
| Cash Cash Equivalents And Short Term Investments | $9,785,000 | $2,618,000 | $10,118,000 | $9,007,000 |
| Cash And Cash Equivalents | $9,785,000 | $2,618,000 | $10,118,000 | $9,007,000 |
| Cash Financial | $9,785,000 | $2,618,000 | $10,118,000 | $9,007,000 |
| Prepaid Assets | - | - | - | $1,144,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $6,105,000 | $7,430,000 | $8,599,000 | $9,466,000 |
| Long Term Debt And Capital Lease Obligation | $4,634,000 | $6,093,000 | $7,391,000 | $8,412,000 |
| Current Debt And Capital Lease Obligation | $1,471,000 | $1,337,000 | $1,208,000 | $1,054,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $28,572,000 | $28,035,000 | $29,675,000 | $26,282,000 |
| Total Non Current Liabilities Net Minority Interest | $4,719,000 | $6,494,000 | $7,942,000 | $8,803,000 |
| Other Non Current Liabilities | $85,000 | $401,000 | $551,000 | $391,000 |
| Current Liabilities | $23,853,000 | $21,541,000 | $21,733,000 | $17,479,000 |
| Other Current Liabilities | $135,000 | $150,000 | $145,000 | $72,000 |
| Current Deferred Liabilities | $15,443,000 | $12,094,000 | $12,776,000 | $11,071,000 |
| Payables And Accrued Expenses | $6,804,000 | $7,960,000 | $7,604,000 | $5,282,000 |
| Payables | $4,248,000 | $5,800,000 | $5,334,000 | $2,868,000 |
| Accounts Payable | $4,248,000 | $5,800,000 | $5,334,000 | $2,868,000 |
| Equity | ||||
| Common Stock Equity | $3,772,000 | $-1,903,000 | $4,636,000 | $9,096,000 |
| Total Equity Gross Minority Interest | $3,772,000 | $-1,903,000 | $4,636,000 | $9,096,000 |
| Stockholders Equity | $3,772,000 | $-1,903,000 | $4,636,000 | $9,096,000 |
| Retained Earnings | $-79,892,000 | $-84,593,000 | $-77,317,000 | $-71,982,000 |
| Other | ||||
| Ordinary Shares Number | $13,705,570 | $13,593,766 | $13,544,228 | $13,522,441 |
| Share Issued | $13,705,570 | $13,714,099 | $13,558,650 | $13,522,441 |
| Tangible Book Value | $3,437,000 | $-2,238,000 | $4,301,000 | $8,761,000 |
| Invested Capital | $3,772,000 | $-1,903,000 | $4,636,000 | $9,096,000 |
| Working Capital | $-1,484,000 | $-7,902,000 | $-2,276,000 | $2,185,000 |
| Capital Lease Obligations | $6,105,000 | $7,430,000 | $8,599,000 | $9,466,000 |
| Total Capitalization | $3,772,000 | $-1,903,000 | $4,636,000 | $9,096,000 |
| Treasury Stock | $708,000 | $708,000 | $74,000 | $0 |
| Additional Paid In Capital | $84,358,000 | $83,384,000 | $82,013,000 | $81,064,000 |
| Capital Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Common Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Long Term Capital Lease Obligation | $4,634,000 | $6,093,000 | $7,391,000 | $8,412,000 |
| Current Deferred Revenue | $15,443,000 | $12,094,000 | $12,776,000 | $11,071,000 |
| Current Capital Lease Obligation | $1,471,000 | $1,337,000 | $1,208,000 | $1,054,000 |
| Current Accrued Expenses | $2,556,000 | $2,160,000 | $2,270,000 | $2,414,000 |
| Goodwill | $335,000 | $335,000 | $335,000 | $335,000 |
| Net PPE | $9,455,000 | $11,973,000 | $14,504,000 | $15,364,000 |
| Accumulated Depreciation | $-11,688,000 | $-10,391,000 | $-8,630,000 | $-5,577,000 |
| Gross PPE | $21,143,000 | $22,364,000 | $23,134,000 | $20,941,000 |
| Leases | $317,000 | $317,000 | $111,000 | $111,000 |
| Construction In Progress | $2,012,000 | $1,891,000 | $2,967,000 | $2,069,000 |
| Other Properties | $16,403,000 | $17,758,000 | $17,708,000 | $16,848,000 |
| Machinery Furniture Equipment | $2,411,000 | $2,398,000 | $2,348,000 | $1,913,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $120,333 | $14,422 | - |
Fetched: 2026-06-13
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $6,997,000 | $-6,973,000 | $1,100,000 | $4,113,000 |
| Operating Activities | ||||
| Operating Cash Flow | $7,386,000 | $-6,137,000 | $3,972,000 | $6,497,000 |
| Cash Flow From Continuing Operating Activities | $7,386,000 | $-6,137,000 | $3,972,000 | $6,497,000 |
| Operating Gains Losses | $293,000 | $435,000 | - | $-4,000 |
| Investing Activities | ||||
| Capital Expenditure | $-389,000 | $-836,000 | $-2,872,000 | $-2,384,000 |
| Investing Cash Flow | $-389,000 | $-836,000 | $-2,872,000 | $-2,384,000 |
| Cash Flow From Continuing Investing Activities | $-389,000 | $-836,000 | $-2,872,000 | $-2,384,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-634,000 | $-74,000 | $0 |
| Financing Cash Flow | $170,000 | $-527,000 | $11,000 | $207,000 |
| Cash Flow From Continuing Financing Activities | $170,000 | $-527,000 | $11,000 | $207,000 |
| Net Common Stock Issuance | $0 | $-634,000 | $-74,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-150,000 | $-146,000 | $0 | $0 |
| End Cash Position | $9,785,000 | $2,618,000 | $10,118,000 | $9,007,000 |
| Beginning Cash Position | $2,618,000 | $10,118,000 | $9,007,000 | $4,687,000 |
| Changes In Cash | $7,167,000 | $-7,500,000 | $1,111,000 | $4,320,000 |
| Proceeds From Stock Option Exercised | $320,000 | $253,000 | $85,000 | $207,000 |
| Common Stock Payments | $0 | $-634,000 | $-74,000 | $0 |
| Net Issuance Payments Of Debt | $-150,000 | $-146,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-150,000 | $-146,000 | $0 | $0 |
| Long Term Debt Payments | $-150,000 | $-146,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-389,000 | $-836,000 | $-2,872,000 | $-2,384,000 |
| Purchase Of PPE | $-389,000 | $-836,000 | $-2,872,000 | $-2,384,000 |
| Change In Working Capital | $-621,000 | $-3,823,000 | $4,243,000 | $2,336,000 |
| Change In Other Working Capital | $3,349,000 | $-683,000 | $1,706,000 | $4,815,000 |
| Change In Other Current Liabilities | $-1,324,000 | $-1,169,000 | $-907,000 | $-631,000 |
| Change In Other Current Assets | $0 | $-169,000 | $0 | - |
| Change In Payables And Accrued Expense | $-1,354,000 | $356,000 | $2,320,000 | $1,157,000 |
| Change In Accrued Expense | $395,000 | $-109,000 | $-145,000 | $183,000 |
| Change In Payable | $-1,749,000 | $465,000 | $2,465,000 | $974,000 |
| Change In Account Payable | $-1,749,000 | $465,000 | $2,465,000 | $974,000 |
| Change In Prepaid Assets | $144,000 | $-167,000 | $-184,000 | $-187,000 |
| Change In Receivables | $-1,436,000 | $-1,991,000 | $1,308,000 | $-2,818,000 |
| Changes In Account Receivables | $-1,436,000 | $-1,991,000 | $1,308,000 | $-2,818,000 |
| Other Non Cash Items | $1,172,000 | $1,066,000 | $952,000 | $786,000 |
| Stock Based Compensation | $654,000 | $1,118,000 | $864,000 | $912,000 |
| Provisionand Write Offof Assets | $-272,000 | $476,000 | $195,000 | $292,000 |
| Deferred Tax | $-181,000 | $0 | - | - |
| Deferred Income Tax | $-181,000 | $0 | - | - |
| Depreciation Amortization Depletion | $1,640,000 | $1,867,000 | $2,246,000 | $1,627,000 |
| Depreciation And Amortization | $1,640,000 | $1,867,000 | $2,246,000 | $1,627,000 |
| Gain Loss On Sale Of PPE | $293,000 | $435,000 | $0 | $-4,000 |
| Net Income From Continuing Operations | $4,701,000 | $-7,276,000 | $-5,335,000 | $548,000 |
| Asset Impairment Charge | - | $0 | $807,000 | $0 |
Fetched: 2026-06-13